Will Novartis sell its big stake in crosstown rival Roche? That’s been the question for years now, as Big Pharma worked its way through blockbuster patent expirations and restructured to compensate--and the queries only grew louder after new chairman Joerg Reinhardt promised to look at all of Novartis’ assets for potential sale.
Now, the answer appears to be yes.